|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effects of roflumilast, a phosphodiesterase-4 inhibitor,on hypoxia-and monocrota- line- induced pulmonary hypertension in rats显示文摘 | Izikki M Raffestin B Klar J | 2009 | J Pharmacol Exp Ther2009，330，1： | 1 |
| 2 | Endotheliabderived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents显示文摘 | Izikki M Guignabert C Fadel E | 2009 | J Clin Invest2009，119，： | 1 |
| 3 | Nebivolol for improvingendothelial dysfunction, pulmonary vascular remodeling, andright heart function in pulmonary hypertension显示文摘 | Perros F Ranchoux B Izikki M | 2015 | J Am CollCardiol2015，65，7： | 1 |
| 4 | Effects of roflu- mi|ast, a phosphodiesterase-4 inhibitor, on hypoxia- and mono- crotaline-induced puhnonary hypertension in rats显示文摘 | IZIKKI M RAFFESTIN B KLAR J et ol | 2009 | J Pharmacol Exp Ther2009，330，1： | 1 |
| 5 | Endothelial-derived FGF2contributes to the progression of pulmonary hypertension in humans and rodents显示文摘 | Izikki M Guignabert C Fadel E | 2009 | J Clin Invest2009，119，3： | 1 |
| 6 | Endothelial-de-rived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents显示文摘 | Izikki M Guignabert C Fadel E | | 0，，03： | 1 |
| 7 | Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension显示文摘 | Guignabert C Izikki M Tu LI et aI | 2006 | Cite Res2006，98，： | 1 |
| 8 | Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension显示文摘 | Perros F Ranchoux B Izikki M | 2015 | J Am Coil Cardiol2015，65，7： | 1 |
| 9 | RhoA and Rho kinase activation in human pulmonary hypertension:role of 5-HT signaling显示文摘 | Guilluy C Eddahibi S Agard C Guignabert C Izikki M Tu L Savale L Humbert M Fadel E Adnot S Loirand G Pacaud P | | 0，，12： | 1 |
| 10 | Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension显示文摘 | Guignabert C Izikki M Tu L I Li Z Zadigue P Barlier-Mur A M Hanoun N Rodman D Hamon M Adnot S Eddahibi S | | 0，，10： | 1 |
| 11 | Effects of roflumilast,a phosphodiesterase-4 inhibitor,on hypoxia-and monocrotaline-induced pulmonary hypertension in rats显示文摘 | Izikki M Raffestin B Klar J | 2009 | J Pharmacol Exp Ther2009，330，1： | 1 |
| 12 | Nebivolol for improving endothelial dysfunction,pulmonary vascular remodeling,and right heart function in pulmonary hypertension显示文摘 | Perros F Ranchoux B Izikki M | 2015 | Journal of the American College of Cardiology2015，65，7： | 1 |
| 13 | Endothelial -de- rived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents显示文摘 | Izikki M Guignabert C Fadel E | 2009 | J Clin Invest2009，119，3： | 1 |
| 14 | Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22 alpha-targeted overexpression of the serotonin transporter显示文摘 | Guignabert C Tu L Izikki M | | 0，，12： | 1 |
| 15 | Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents显示文摘 | Izikki M Guignabert C Fadel E | 2009 | J Clin Invest2009，119，3： | 1 |
| 16 | Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism:effects on hypoxic pulmonary hypertension in mice显示文摘 | Izikki M Hanoun N Marcos E | 2007 | Am J Physiol Lung Cell Mol Physiol2007，293，4： | 1 |
| 17 | Nebivolol for im- proving endothelial dysfunction, pulmonary vascular re-modeling, and right heart function in pulmonary hyperten- sion显示文摘 | Perros F Ranchoux B Izikki M | 2015 | J Am Coll Cardiol2015，65，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员